Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Aljada

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
The American Journal of Medicine|December 18, 2003
Vascular reactivity and thiazolidinedionesParesh Dandona, Ahmad Aljada, Ajay Chaudhuri
Metabolic Syndrome and Related Disorders|March 29, 2008
Lipids, carbohydrates, and heart diseaseAhmad Aljada, Priya Mohanty, Paresh Dandona
Trends in Immunology|December 31, 2003
Inflammation: the link between insulin resistance, obesity and diabetesParesh Dandona, Ahmad Aljada, Arindam Bandyopadhyay
The Medical Clinics of North America|August 17, 2004
Endothelial dysfunction and hypertension in diabetes mellitusParesh Dandona, Ajay Chaudhuri, Ahmad Aljada
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Expanding the Role of Heparin Derivatives in Oncology: From Anticoagulation to Antitumor ActivityJasmine Holail, Hatouf Husni Sukkarieh, Ahmad Aljada
Current Opinion in Investigational Drugs (London, England : 2000)|September 28, 2010
Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applicationsAhmad Aljada, Lynn Dong, Shaker A Mousa
Reviews in Endocrine & Metabolic Disorders|June 24, 2004
Endothelial dysfunction, inflammation and diabetesParesh Dandona, Ahmad Aljada, Ajay Chaudhuri, et al.
PPAR Research|August 22, 2009
Peroxisome proliferator-activated receptor agonists: do they increase cardiovascular risk?Ahmad Aljada, Kshitij Ashwin Shah, Shaker A Mousa
Clinical Cornerstone|February 28, 2004
Insulin as an anti-inflammatory and antiatherosclerotic hormoneParesh Dandona, Ahmad Aljada, Sandeep Dhindsa, et al.
Diagnostic Pathology|June 3, 2014
Modulation of insulin/IGFs pathways by sirtuin-7 inhibition in drug-induced chemoreistanceAhmad Aljada, Ayman M Saleh, Salem Al Suwaidan
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
The American Journal of Medicine|December 18, 2003
Vascular reactivity and thiazolidinedionesParesh Dandona, Ahmad Aljada, Ajay Chaudhuri
Metabolic Syndrome and Related Disorders|March 29, 2008
Lipids, carbohydrates, and heart diseaseAhmad Aljada, Priya Mohanty, Paresh Dandona
Trends in Immunology|December 31, 2003
Inflammation: the link between insulin resistance, obesity and diabetesParesh Dandona, Ahmad Aljada, Arindam Bandyopadhyay
The Medical Clinics of North America|August 17, 2004
Endothelial dysfunction and hypertension in diabetes mellitusParesh Dandona, Ajay Chaudhuri, Ahmad Aljada
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Expanding the Role of Heparin Derivatives in Oncology: From Anticoagulation to Antitumor ActivityJasmine Holail, Hatouf Husni Sukkarieh, Ahmad Aljada
Current Opinion in Investigational Drugs (London, England : 2000)|September 28, 2010
Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applicationsAhmad Aljada, Lynn Dong, Shaker A Mousa
Reviews in Endocrine & Metabolic Disorders|June 24, 2004
Endothelial dysfunction, inflammation and diabetesParesh Dandona, Ahmad Aljada, Ajay Chaudhuri, et al.
PPAR Research|August 22, 2009
Peroxisome proliferator-activated receptor agonists: do they increase cardiovascular risk?Ahmad Aljada, Kshitij Ashwin Shah, Shaker A Mousa
Clinical Cornerstone|February 28, 2004
Insulin as an anti-inflammatory and antiatherosclerotic hormoneParesh Dandona, Ahmad Aljada, Sandeep Dhindsa, et al.
Diagnostic Pathology|June 3, 2014
Modulation of insulin/IGFs pathways by sirtuin-7 inhibition in drug-induced chemoreistanceAhmad Aljada, Ayman M Saleh, Salem Al Suwaidan
Pageof 9